Association between circulating cytokines expression patterns and outcomes to immune-checkpoint (ICI)-based regimens in metastatic renal cell carcinoma (mRCC)

被引:0
|
作者
Linville, Laura Meili
Feinaj, Ardit
Nathani, Kaizen
Singla, Nirmish
Yarchoan, Mark
Markowski, Mark Christopher
Carducci, Michael Anthony
Munjal, Kabeer
Thoburn, Christopher
Gizzi, Jennifer
Kao, Chester
Elias, Roy
Ged, Yasser
机构
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4547
引用
收藏
页数:1
相关论文
共 50 条
  • [1] RACIAL DIFFERENCES IN OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS MANAGED ON IMMUNE-CHECKPOINT INHIBITOR (ICI) THERAPY
    Olsen, T. Anders
    Martini, Dylan
    Goyal, Subir
    Liu, Yuan
    Evans, Sean
    Magod, Benjamin
    Brown, Jacqueline
    Yantorni, Lauren
    Russler, Greta
    Caulfield, Sarah
    Goldman, Jamie
    Nazha, Bassel
    Harris, Wayne
    Master, Viraj
    Kucuk, Omer
    Carthon, Bradley
    Bilen, Mehmet
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A133 - A133
  • [2] Association of circulating tumor cells (CTCs) with immune checkpoint inhibitor (ICI) responses in metastatic renal cell carcinoma (mRCC)
    Zhang, T.
    Poellmann, M.
    Park, S-J.
    Bu, J.
    Zhao, R.
    Zhou, Q.
    Agarwal, A.
    Parks, J.
    Reyes-Martinez, M.
    Armstrong, A. J.
    George, D. J.
    Wang, A. Z.
    Hong, S.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1221 - S1221
  • [3] Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC).
    Dizman, Nazli
    Govindarajan, Ameish
    Zengin, Zeynep Busra
    Meza, Luis A.
    Tripathi, Nishita
    Sayegh, Nicolas
    Castro, Daniela V.
    Chan, Elyse H.
    Lee, Kyle O.
    Prajapati, Sweta R.
    Feng, Matthew I.
    Loo, Vivian
    Pace, Makala
    O'brien, Shea
    Bailey, Erin B.
    Barragan-Carrillo, Regina
    Chehrazi-Raffle, Alex
    Li, Xiaochen
    Agarwal, Neeraj
    Pal, Sumanta Monty
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis
    Araujo, Daniel, V
    Wells, J. Connor
    Hansen, Aaron R.
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun L.
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    Dudani, Shaan
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (05) : 820 - 826
  • [5] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis.
    Araujo, Daniel Vilarim
    Wells, Connor
    Hansen, Aaron Richard
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun Loo
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Dudani, Shaan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
    Elias, Roy
    Levonyak, Nicholas
    Christie, Alana
    Bowman, Isaac Alexander
    Kapur, Payal
    Hannan, Raquibul
    Hammers, Hans J.
    Brugarolas, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [7] Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC)
    Araujo, Daniel Vilarim
    Malone, Eoghan Ruadh
    Sacher, Adrian G.
    Fallah-Rad, Nazanin
    Sridhar, Srikala S.
    Hansen, Aaron Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean T.
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [9] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [10] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    George, Saby
    Morrison, Carl
    Zhang, Tian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)